ARTICLE | Company News
Biosite Diagnostics Inc., MorphoSys deal
January 4, 2000 8:00 AM UTC
MOR received a non-exclusive revenue-bearing license from BSTE to practice and allow partners to practice multi-chain antibody phage display to develop antibodies from MOR's HuCAL antibody libraries. ...